4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-23-018566
Chief Executive Officer gave up 9,444 shares (to pay taxes)
- Chief Executive Officer acquired 20,833 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2023-03-10 | Option exercise | +11,833 | 387,821 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2023-03-13 | Shares withheld for taxes | −5,358 | $43.22 | $231,573 | 382,463 | D |
| Kulkarni Samarth Chief Executive Officer | 2023-03-11 | Option exercise | +9,000 | 391,463 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2023-03-13 | Shares withheld for taxes | −4,086 | $43.22 | $176,597 | 387,377 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2023-03-10 | Option exercise · Restricted Stock Units | −11,833 | 0 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2023-03-10 | Grant or award · Stock Option (Right to Buy) | +188,000 | 188,000 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2023-03-10 | Grant or award · Restricted Stock Units | +77,000 | 77,000 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2023-03-11 | Option exercise · Restricted Stock Units | −9,000 | 18,000 | D | ||
Loading xslF345X03/doc4.xml…